michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, Tracy, let me start and Dan can fill in whatever I miss. We're actually not trying to forecast CPI or inflation generally. We're trying to forecast loss cost. And we do that by analyzing our own data and incorporating forecasts from third-parties and we do that on a very granular basis. So, take workers' comp, for example. We're not forecasting medical inflation, we're looking at components, so think prescription drug prices, durable medical equipment, etc. And we're doing that in the same mix that those loss costs contribute to our actual losses. So it's hard, I mean, obviously we can't give you a single number. And it's hard to say, go look at this index or that index because we're doing it on a very granular basis, in part, by tumbling our own data, squaring triangles and by reference to third-party sources.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, so Mig, this is Barry. I'll just tell you that our constraint right now relative to capacity is really manpower. We do not believe that we have to increase anything around brick and mortar. Obviously as you know, we've taken action to try and reduce our footprint capacity, but we're confident that with the improvements that we've started and already see in our operational excellence initiatives that we should be able to achieve any type of -- any additional spike in demand with the brick and mortar that we have today.
Obviously in 2020, we only spent I think around $15 million in capex which lower than what we want it to be. And so, as we start to beef up our operational excellence initiatives, obviously, we want to invest in creativity over capital first, but we know that there's things that we can do more of relative to automation and efficiencies through more capital expenditure. And so, we've worked very closely and continue to work closely with our manufacturing engineering and operational people in order to really identify those areas of opportunity that will help us with the demand we see today, but with additional demand that we see in the future.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, on the margin, we're adding back some flights into the winter schedule. But as you know, winter is never the peak season for Europe travel. So what we're really thinking is, given the lifting of these embargoes, it's going to make for a great spring and summer season next year. And so a lot of our rebuild costs and a lot of the things we're preparing for to have our European largely intact by summer.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Daniel has covered it really well. We've had this very strong targets for the last few years of always replacing depletion. The sites are performing very well. We're fairly confident we'll make that target. And over the last few years, we've seen consistent growth at Jacobina, and I think we'll see that again this year. And then obviously, at Canadian Malartic, we're going to see some growth in resources there, and perhaps the conversion of some of that inferred to -- indicated for that February release as well.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Tom, do you want to take that?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you, Deane.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think we're around 4,000 certified eyecare professionals in the U.S. right now. I don't have the number off the top of my head. I know it's larger than that outside of the U.S.
To be honest with you, I've kind of stopped looking at it just because there's so much variability around fitting and how much people fit. Anyone who's really interested in myopia management has a tendency to fit a lot. And then we're getting a lot of eye care professionals come in that are kind of new, that are doing one or two or just getting started. We're also starting to see people outside of the traditional optometrist, if you will, getting certified on that because you're getting some staff and some other people who are now responsible for, right? The optometrist doesn't want to spend their time educating mom and dad on what myopia is and how it progresses and so forth.
So you kind of see a broadening of some of the trading activity, but it continues to increase. I know we continue to get a pretty decent number of certifications coming through on a monthly basis.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So this is -- so I'll start it out with some of the regional players. We're net -- certainly net adding from a regional player perspective, meaning selling versus losing, I think many of the regional players are struggling in this environment to provide as many -- as much value through COVID. The speed at which regulations are changing and demands on small and midsized businesses for vaccination policy, the mandate what's the latest, you're going to get that from someone like us. And in fact, many smaller players try to copy our stuff up, the web we have, a very comprehensive website from marketing that puts all the information out, by state.
Telling you what you have to do, where you have to do it. And then here's the products that will help you with that from a technology and a service standpoint. So I think it's really been more difficult on the regional players today that just don't have the breadth of service knowledge or compliance people to be able to keep up with this. We have over 200 compliance experts that follow every single thing that's happening that may happen so that we can be as agile, as Efrain mentioned earlier, on creating these products almost as soon as the issues come out.
So very strong from a regional competitor standpoint on the net adds that we've seen year to date. Do you want to take the --

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. No. So, good question. We don't get any pressure generally speaking from build-to-rent operators as they're -- typically those neighborhoods are much further out relative to our portfolio. But we're always being approached by build-to-rent developers, other landowners to see if we'd be interested in parts or whole sections of communities.
We apply really the same thinking that we do to buying an individual home which is, do we like that location and are we long-term believers in the fundamentals around that neighborhood? We certainly own parts or whole neighborhoods around different markets in the country, but generally they're much more infill in nature.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, I mean, if you may remember, the Galvanize business is really sort of three pieces. There was a direct-to-consumer piece, there's an enterprise piece, and there was a non-workforce piece around what they call a community business, a like a WeWork type of real estate business. And I think, obviously, in the past year, since the pandemic hit, that third lake or that store [Phonetic] just crumbled underneath us. And so we closed the acquisition early in the first calendar quarter of last year, and then the pandemic hit sort of late in that calendar quarter. And so, virtually this entire year, we were hit -- our fiscal '21, we had a very, very weak community business.
In addition, the pipeline in the enterprise business did not materialize in the way that we thought it would, and so the enterprise business also underperformed. The consumer -- they have a great consumer product, and I think that consumer product is going to continue to thrive. They place their students in a lot of the preeminent technology companies across the country. And so, I think that trend is going to continue, and we're going to double down on consumer business and cut out the costs from those other businesses and turn this thing around this year. And so, while it may be smaller, overall than what we had originally expected, I still think we can put it onto a path to create a lot of value for us.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No, I don't think we -- I think we should stay away from our percentage. We have converted some big customers, one of our -- one of our top five customers. But it really varies, and it's going to be a little bit uneven. We're going to be really focused on this over the next few months or two[Phonetic]. Maybe we'll have some more clarity and be in a position to report percentages then, but now it's a little bit too early.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Kennen, I just want to add some color here. Obviously, you have heard what Rudolf is trying to communicate to everybody with regard to the fact that the current discussion with FDA was positive. FDA was encouraging us to further develop a [Indecipherable] value in light of profile of what we have. But certainly, we have to address the concerns. Now if the concern is safety then the study design is only focused on safety.
So therefore, to end back on doing a study without having a good communication, FDA will not be an ideal situation. It's always nice to have an agreed study design, hopefully not a big one and then that actually will allow us to accelerate the path going forward with FDA together. Now in relation to that, Rudolf also mentioned that there's an alternative path with regard to angiosarcoma. So how to balance these two in such a way that we can satisfy FDA's concern at the same time, giving the product the best half forward for approval?
I think that we are in a very interesting position. We have more than one path and then we have multiple opportunities, and we're trying to make the right decisions so as to use the capital and time efficiently to -- for this product to be available to patients. I think that summarized actually in a different way, Rudolf's comments. Kennen?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good afternoon. Maybe for Marcel and Barry. You guys have been at this for a long time and, you know, The Wall Street Journal wrote a piece, I think was early December, suggesting a permanent impairment of business travel to the tune of 20% or 30%. What are your thoughts on that? Is that a bit of a stretch? Do you think there's some truth to that? Do you think the Zoom environment is going to hedge the, you know, business travel by some degree? Can -- can you expand upon that?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. Yes, so thanks for the question, Liisa. I mean, others have tried to do this and haven't always been able to progress their programs. And so as we were working on this program actually for years, optimizing molecules coming up with ones that were exclusively potent had very, very nice drug-like properties. And importantly safely, I mean, we usually don't talk a lot about pre-clinical safety, because it's an enabler to get you to the real clinical data. But we've done a very extensive work up and have gone through 13-week tox and multiple species. So the molecule looks incredibly good by every measure that we've looked at it from a virologic perspective, from a DMPK and also from a safety perspective, it's a very, very nice molecule.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Todd, may I ask you to address this?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, we do, Brad. I mean the data we look at the moment is, as we've talked about, is taking into consideration, we have had share declines, but that be natural and accounted for based on the store closures. So we had about an 80% drop in our revenue out of those. We've retained about 20% and so our share has been stable and sequential.
That tells us the customer believes is still shopping up and we have category authority that we can ignite further. I do think in the interim, based on these pressures that you see with COVID, we are seeing some shift to interim shift to single-point destination shopping. So food and essentials driving choices at the outset. We think that that is a moment in time, and we think there's further opportunity to grow with the right targeted marketing as you say.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I think the gives and takes are, as you're probably going to predict we'll say is we always know there's weather we have to deal with in North Dakota. And so if you get a calm early winter then yeah, I think that could provide some upside. We do have a lot of well connects forecasted in the last couple months of the year. That's what producers are telling us.
But if you get some weather, could those be delayed? I think the key -- potential so. But I think the key is we have kind of this arbitrary cutoff at December 31. Well, the well connects are going to get done rather it's in on December 15th or January 15th. So as we think -- if we back up and look at the trends over the next several months, clearly we've got optimism of where we're going to be.
But I think, yes, you've hit on -- there are -- I think there's some upside as well with both volumes if these wells come on line like we think and as well as the ethane recovery option that would be a positive upside for us in the fourth quarter.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, there. So Jeff, you were talking about how the CTV open Internet consortium was integrating into 2.0. And then, you said fubo was integrating directly into 2.0. I was wondering how that affects your ability to target whether people are going indirect like in affiliating versus like fubo directly integrating into 2.0.
And then, my second one is on the Walmart deal. Are we still on track to be fully integrated with Walmart by 4Q? And as your -- do you get paid on that because you get the 15% platform fee? Is that how you make money on the Walmart deal when CPG spends money on your platform? Thank you.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, good morning, guys.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks for the question. There's nothing that I think is not obvious. I think the reality is that COVID has a -- and has obviously, shown a very large impact on not just our business but broader e-commerce. And the myriad of factors that impact global e-commerce and us, in particular, are subject to those COVID-related variables that are just impossible to forecast.
And, therefore, what they create for us is really an unreasonably wider range of entirely possible outcomes to make guidance effectively not very useful for anyone. So I think -- the bottom line is that the level of risk and the associated ranges really make guidance not particularly relevant and extraordinarily difficult this year for us just given those uncertainties.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, everyone, for joining the call. Thank you for hanging in there a little longer than normal. Bob Landry and the investor relations team will be around after the call. We hope you enjoy your weekend. Please stay safe.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Great. Thanks a lot. Congratulations on the good Q4 numbers. So yes, just maybe a couple of follow-ups to some prior questions.
I know you've kind of talked about this at a high level, but is it possible to roughly estimate or just sort of like a ballpark number in terms of how much COVID impacted billings growth in fiscal '21? And then just can you talk about how you feel about your visibility today relative to three to six months ago? And then just how you see -- how long do you think it takes customer spending patterns to return fully to pre-pandemic levels? Thanks.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Thanks, Michael. I -- certainly, I see in our industry with the number of publicly listed companies in the gold space is order of magnitude more than any other commodity. That in itself says there's an opportunity for consolidation in terms of the additional [Indecipherable] that you have. The elevated gold prices, I think, probably hold off a lot of that consolidation. I think I don't believe that it will be necessarily some of this near to medium-term cost escalation that will drive consolidation. I think the -- and I believe that the issue around the work that needs to take place for all mining companies to achieve 2030 carbon reduction targets, greenhouse gas reduction targets and ambitions to achieve net 0 by 2050, which we're clearly seeing many governments around the world sign up to in order to achieve those targets, you will need scale and you will need life. And over the course of this decade, we will see consolidation driven by that imperative. So I predict climate change will be the driver rather than some near-term COVID related escalation.

    Prediction (one of UP, DOWN, SAME): SAME